System and method for reducing partial voluming artifacts in quantitative myocardial tissue characterization
10451700 ยท 2019-10-22
Assignee
Inventors
Cpc classification
G01R33/5608
PHYSICS
G01R33/56545
PHYSICS
G01R33/5602
PHYSICS
G01R33/50
PHYSICS
G01R33/5607
PHYSICS
International classification
G01R33/565
PHYSICS
G01R33/56
PHYSICS
Abstract
A system and method for obtaining magnetic resonance images are provided. The system is programmed to control the RF system to apply a saturation pulse at a reference frequency that saturates a selected labile spin species of the subject. The system is programmed to control the RF system to apply an inversion pulse after a variable delay. The system is programmed to control the RF system and the plurality of gradient coils to apply a motion sensitized driven equilibrium (MSDE) preparation pulse. The system is programmed to control the plurality of gradient coils to read imaging data during an acquisition time period. The system is programmed to reconstruct a T.sub.1 mapping image of the subject with black-blood contrast.
Claims
1. A magnetic resonance imaging (MRI) system comprising: a magnet system configured to generate a polarizing magnetic field about at least a region of interest (ROI) in a subject arranged in the MRI system; a plurality of gradient coils configured to apply a gradient field to the polarizing magnetic field; a radio frequency (RF) system configured to apply an excitation field to the subject and acquire MR image data from the ROI; a computer system programmed to: control the RF system to apply a saturation pulse at a reference frequency that saturates a selected labile spin species of the subject; control the RF system to apply an inversion pulse after a variable delay; control the RF system and the plurality of gradient coils to apply a blood suppression preparation pulse; control the plurality of gradient coils to read imaging data during an acquisition time period; and reconstruct a T1 mapping image of the subject with black-blood contrast.
2. The MRI system of claim 1 wherein the blood suppression preparation pulse includes a motion sensitized driven equilibrium (MSDE) preparation pulse.
3. The MRI system of claim 2 wherein the computer system is programmed to perform a balanced Steady-State Free-Precession (bSSFP) imaging readout after applying the MSDE preparation pulse.
4. The MRI system of claim 3 wherein the MSDE preparation pulse comprises a non-selective 90 tip-down pulse, a series of one or more 180 refocusing pulses, and a final 90 tip-up pulse.
5. The MRI system of claim 2 wherein the MSDE preparation pulse has an echo time between 11 ms and 15 ms.
6. The MRI system of claim 2 wherein the MSDE preparation pulse comprises a rectangular 90 hard-pulses for tip-down and tip-up and a single 180 MLEV refocusing pulse.
7. The MRI system of claim 2 wherein the MSDE preparation pulse comprises a rectangular 90 hard-pulse for tip-down, an adiabatic 180 BIREF1 refocusing pulse and a composite (360-270) tip-up pulse.
8. The MRI system of claim 2 wherein the MSDE preparation pulse comprises a 0 degree three compartment BIR4 pulse, wherein the MSDE gradients are inserted symmetrically between the compartments.
9. The MRI system of claim 2 wherein the computer system is programmed to perform imaging at late end-diastole to accommodate the MSDE preparation well within the end-diastolic quiescence.
10. The MRI system of claim 1 wherein the blood suppression preparation pulse employs a pulse train of velocity and shear sensitizing pulses to suppress blood signal.
11. A method comprising: controlling, by a magnetic resonance imaging (MRI) system, a radio frequency (RF) system to apply a saturation pulse at a reference frequency that saturates a selected labile spin species of the subject; controlling the RF system to apply an inversion pulse after a variable delay; controlling the RF system and the plurality of gradient coils to apply a blood suppression preparation pulse; controlling the plurality of gradient coils to read imaging data during an acquisition time period; and reconstructing a T1 mapping image of the subject with black-blood contrast.
12. The method of claim 11 wherein the blood suppression preparation pulse includes a motion sensitized driven equilibrium (MSDE) preparation pulse.
13. The method of claim 12 further comprising: performing a balanced Steady-State Free-Precession (bSSFP) imaging readout after applying the MSDE preparation pulse.
14. The method of claim 13 wherein the MSDE preparation pulse comprises a non-selective 90 tip-down pulse, a series of one or more 180 refocusing pulses, and a final 90 tip-up pulse.
15. The method of claim 12 wherein the MSDE preparation pulse has an echo time between 11 ms and 15 ms.
16. The method of claim 12 wherein the MSDE preparation pulse comprises a rectangular 90 hard-pulses for tip-down and tip-up and a single 180 MLEV refocusing pulse.
17. The method of claim 12 wherein the MSDE preparation pulse comprises a rectangular 90 hard-pulse for tip-down, an adiabatic 180 BIREF1 refocusing pulse and a composite (360-270) tip-up pulse.
18. The method of claim 12 wherein the MSDE preparation pulse comprises a 0 degree three compartment BIR4 pulse, wherein the MSDE gradients are inserted symmetrically between the compartments.
19. The method of claim 12 further comprising: performing imaging at late end-diastole to accommodate the MSDE preparation well within the end-diastolic quiescence.
20. The method of claim 11 further comprising: applying the blood suppression preparation pulse that employs a pulse train of velocity and shear sensitizing pulses to suppress blood signal.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
DETAILED DESCRIPTION
(27) Referring particularly now to
(28) The pulse sequence server 110 functions in response to instructions downloaded from the operator workstation 102 to operate a gradient system 118 and a radiofrequency (RF) system 120. Gradient waveforms necessary to perform the prescribed scan are produced and applied to the gradient system 118, which excites gradient coils in an assembly 122 to produce the magnetic field gradients G.sub.x, G.sub.y, and G.sub.z used for position encoding magnetic resonance signals. The gradient coil assembly 122 forms part of a magnet assembly 124 that includes a polarizing magnet 126 and a whole-body RF coil 128.
(29) RF waveforms are applied by the RF system 120 to the RF coil 128, or a separate local coil (not shown in
(30) The RF system 120 also includes one or more RF receiver channels. Each RF receiver channel includes an RF preamplifier that amplifies the magnetic resonance signal received by the coil 128 to which it is connected, and a detector that detects and digitizes the I and Q quadrature components of the received magnetic resonance signal. The magnitude of the received magnetic resonance signal may, therefore, be determined at any sampled point by the square root of the sum of the squares of the I and Q components:
M={square root over (I.sup.2+Q.sup.2)}Eqn. 1;
and the phase of the received magnetic resonance signal may also be determined according to the following relationship:
(31)
(32) The pulse sequence server 110 also optionally receives patient data from a physiological acquisition controller 130. By way of example, the physiological acquisition controller 130 may receive signals from a number of different sensors connected to the patient, such as electrocardiograph (ECG) signals from electrodes, or respiratory signals from a respiratory bellows or other respiratory monitoring device. Such signals are typically used by the pulse sequence server 110 to synchronize, or gate, the performance of the scan with the subject's heart beat or respiration.
(33) The pulse sequence server 110 also connects to a scan room interface circuit 132 that receives signals from various sensors associated with the condition of the patient and the magnet system. It is also through the scan room interface circuit 132 that a patient positioning system 134 receives commands to move the patient to desired positions during the scan.
(34) The digitized magnetic resonance signal samples produced by the RF system 120 are received by the data acquisition server 112. The data acquisition server 112 operates in response to instructions downloaded from the operator workstation 102 to receive the real-time magnetic resonance data and provide buffer storage, such that no data is lost by data overrun. In some scans, the data acquisition server 112 does little more than passing the acquired magnetic resonance data to the data processor server 114. However, in scans that require information derived from acquired magnetic resonance data to control the further performance of the scan, the data acquisition server 112 is programmed to produce such information and convey it to the pulse sequence server 110. For example, during prescans, magnetic resonance data is acquired and used to calibrate the pulse sequence performed by the pulse sequence server 110. As another example, navigator signals may be acquired and used to adjust the operating parameters of the RF system 120 or the gradient system 118, or to control the view order in which k-space is sampled. In still another example, the data acquisition server 112 may also be employed to process magnetic resonance signals used to detect the arrival of a contrast agent in a magnetic resonance angiography (MRA) scan. By way of example, the data acquisition server 112 acquires magnetic resonance data and processes it in real-time to produce information that is used to control the scan.
(35) The data processing server 114 receives magnetic resonance data from the data acquisition server 112 and processes it in accordance with instructions downloaded from the operator workstation 102. Such processing may, for example, include one or more of the following: reconstructing two-dimensional or three-dimensional images by performing a Fourier transformation of raw k-space data; performing other image reconstruction algorithms, such as iterative or backprojection reconstruction algorithms; applying filters to raw k-space data or to reconstructed images; generating functional magnetic resonance images; calculating motion or flow images; and so on.
(36) Images reconstructed by the data processing server 114 are conveyed back to the operator workstation 102 where they are stored. Real-time images are stored in a data base memory cache (not shown in
(37) The MRI system 100 may also include one or more networked workstations 142. By way of example, a networked workstation 142 may include a display 144; one or more input devices 146, such as a keyboard and mouse; and a processor 148. The networked workstation 142 may be located within the same facility as the operator workstation 102, or in a different facility, such as a different healthcare institution or clinic.
(38) The networked workstation 142, whether within the same facility or in a different facility as the operator workstation 102, may gain remote access to the data processing server 114 or data store server 116 via the communication system 117. Accordingly, multiple networked workstations 142 may have access to the data processing server 114 and the data store server 116. In this manner, magnetic resonance data, reconstructed images, or other data may exchange between the data processing server 114 or the data store server 116 and the networked workstations 142, such that the data or images may be remotely processed by a networked workstation 142. This data may be exchanged in any suitable format, such as in accordance with the transmission control protocol (TCP), the internet protocol (IP), or other known or suitable protocols.
(39) Quantitative tissue characterization of the myocardium using cardiac magnetic resonance imaging (CMR) is a promising diagnostic tool with clinical value in numerous cardiomyopathies. Recently, native myocardial T.sub.1 mapping has also shown prognostic value in pathologies with reduced myocardial wall thickness, such as dilated cardiomyopathy (DCM). For example, myocardial T.sub.1 mapping may be performed using a series of end-diastolic single-shot images acquired within a single breath-hold. Variable magnetization preparation of the single-shot images induces varying T.sub.1 weighted contrast and enables voxel-wise T.sub.1 quantification.
(40) However, the limited duration of the diastolic quiescence requires rapid imaging and restricts the in-plane resolution. This leads to major partial-voluming effects at the myocardial-blood interface due to substantial differences in their respective T.sub.1 times. Partial-voluming reduces the myocardial area that is suitable for quantitative evaluation, impairs the reproducibility, and hampers the depiction of thin structures.
(41) Segmented acquisition of the T.sub.1 weighted images has been proposed to mitigate this shortcoming by improving the in-plane resolution. Similarly, T.sub.1 quantification at systole has been proposed to increase the number of voxels within the myocardium that are not subject to partial voluming. However, residual partial-voluming may still be expected even at higher resolutions or with increased myocardial wall thickness, especially in oblique orientations. Another approach to overcome this issue is blood-suppression. In-flow saturation at the great vessels may also be used to induce black-blood contrast in the pre-clinical mouse model.
(42) In this disclosure, a black-blood T.sub.1 mapping method is provided by using combined saturation and inversion recovery and MSDE magnetization preparation. Numerical simulations were performed to study the effects of blood-suppression on partial-voluming. Phantom scans and in-vivo experiments in healthy volunteers were carried out to optimize the black-blood imaging parameters and to evaluate the proposed method on efficient blood signal suppression and homogeneous T.sub.1 quantification.
(43) One non-limiting example of a pulse sequence in accordance with the present disclosure is provided in
(44) Referring particularly to
(45) Conventional SAPPHIRE consists of a saturation pulse followed by a non-selective inversion, creating only weak contrast between blood and myocardial signal, as indicated by the red crosses in
(46)
(47) Additionally, there is one spoiler gradient 234 on Gx after applying the 90 tip-up pulse 226. There is one spoiler gradient 244 on Gy after applying the 90 tip-up pulse 226. There is one spoiler gradient 254 on Gz after applying the 90 tip-up pulse 226.
(48)
(49) Here, the MSDE implementation the black-blood gradients may be played out with all three gradient coils, a maximum gradient amplitude of 20 mT/m per coil and a slew-rate of 150 mT/m/ms (ramp durations of 0.14 ms). Motion-sensitizing gradient duration may be maximized within the gaps between the respective tip-up/-down and the refocusing pulse. The MSDE echo time may be fixed to TE.sub.MSDE=11 ms, if not stated otherwise.
(50) The sequence in
(51)
(52) For example, numerical simulations of a bi-compartment model may be performed to study the effect of partial-voluming on the T.sub.1 estimation in a SAPPHIRE sequence. A myocardial-tissue compartment may be simulated with T.sub.1/T.sub.2=1580 ms/50 ms and a blood-compartment with T.sub.1/T.sub.2=2300 ms/250 ms. Relative signal-to-noise ratio (SNR) of the components with or without MSDE preparation pulse, may be simulated as follows: Without MSDE: Myocardium/Blood=117/119; With MSDE: Myocardium/Blood=95/11. The relative compartmental share between the blood and myocardium may be varied between 0% and 100%. The overall signal of the SAPPHIRE sequence with and without MSDE preparation may be simulated using the Bloch-equations. A three-parameter fit to the simulated signal may yield the T.sub.1 time.
(53) To study the visual effects of partial-voluming, a numerical representation of a cardiac short-axis slice was simulated with blood and myocardial compartments of the left and right ventricle. The numerical phantom was generated with a matrix size of 10241024 pixels and subsequently down-sampled to matrix-sizes corresponding to approximate pixel resolutions of 1.01.03.03.0 mm.sup.2 in order to induce partial-voluming. To facilitate comparability between different resolutions, all images were then up-sampled to a reconstruction resolution of 0.750.75 mm.sup.2 prior to further processing. Bloch-equations were used to simulate voxel-wise signals of the numerical phantom, using the same myocardium and blood compartments as described above. Subsequent fitting with a three-parameter model may be used to generate the T1 maps. The three-parameter model avoids quantification inaccuracies caused by MSDE signal reduction.
(54) In this disclosure, the imaging sequence may be performed on a 3T scanner (Magnetom Skyra; Siemens Healthcare, Erlangen, Germany) with a 30 channel receive array. The T.sub.1 mapping sequences may be performed with the following imaging parameters: TR/TE=2.9/1.0 ms, flip-angle=45, bandwidth=1085 Hz/Px, FOV=400300 mm.sup.2, in-plane resolution=2.12.1 mm.sup.2, partial-fourier=6/8, GRAPPA-factor 2, number of phase-encoding steps=56. The flip-angle may be adjusted when specific absorption rate (SAR) limitations are reached.
(55)
(56)
(57)
(58) For example, imaging may be performed in a static phantom to study B.sub.1.sup.+ uniformity of various MSDE preparation modules and to verify the accuracy of the black-blood SAPPHIRE sequence. The following three MSDE preparation modules with different combinations of RF pulses were tested for B.sub.1.sup.+ uniformity in a homogeneous phantom containing NaCl-doped water:
(59) 1) Rectangular 90 hard-pulses for tip-down and tip-up and a single 180 MLEV refocusing pulse.
(60) 2) A rectangular 90 hard-pulse for tip-down, an adiabatic 180 BIREF1 refocusing pulse and a composite (360-270) tip-up pulse.
(61) 3) A 0 degree three compartment BIR4 pulse, with the MSDE gradients inserted symmetrically between the compartments.
(62) As shown in
(63) The echo-time of the three MSDE modules may be fixed to TE.sub.MSDE=15 ms. B.sub.1.sup.+ uniformity was assessed as the signal of a MSDE prepared single-shot image normalized by the signal of a single-shot image without MSDE preparation. The MRI may use other imaging parameters as described above.
(64) Furthermore, accuracy of the SAPPHIRE black-blood sequence was evaluated in phantom scans. The phantom was composed of seven vials containing agarose-gel doped with various concentrations of gadoterate meglumine (Dotarem; Guerbet, Aulnay-sous-Bois, France) to achieve T.sub.1 and T.sub.2 times in the physiological range. The combination of composite-pulses and the adiabatic refocusing was used for MSDE preparation in the remainder of the study. Conventional SAPPHIRE without MSDE preparation was performed as a reference.
(65)
(66) In an in-vivo experiment, the black-blood preparation was optimized in a cohort of five healthy subjects (3 male, 294 years old). Baseline images without saturation/inversion preparation, as acquired in the SAPPHIRE black-blood sequence, were obtained with varying the echo time TE.sub.MSDE from 10 ms to 15 ms. The effectiveness of blood-suppression was quantitatively analyzed as the contrast-tonoise ratio (CNR) between the left-ventricular myocardium and the left-ventricular blood-pool. To capture the effects of stagnant blood in the CNR, manually drawn endocardial contours, covering the entire LV blood-pool were used for signal analysis of the blood. Signal heterogeneity in the myocardium, caused by the MSDE preparation, was quantitatively analyzed as the coefficient of variance (COV) of the signal over the entire myocardium between the epiand the endocardial contours.
(67)
(68) In
(69) In another in-vivo experiment, a separate cohort of eight healthy volunteers (4 male, 284 years old) was recruited for T.sub.1 time analysis. Imaging was performed using standard and black-blood SAPPHIRE in three short-axis slices and one four-chamber slice. T.sub.1 times were evaluated using manually drawn ROIs. Average segmental T.sub.1 times were assessed according to the AHA 16-segment model. Precision was obtained as the average inter-segment variation. The average myocardial thickness was assessed between the manually drawn epi- and endocardial contours: 1000 spokes through the center of mass were uniformly spread around the myocardium. Thickness was then defined as the average distance of the crossing point of the spoke with the endo- and epicardial border, respectively. T.sub.1 times, T.sub.1 time precision and average myocardial ROI thickness were compared between conventional and black-blood SAPPHIRE on a per subject basis using student's t-test. P-values<0.05 were considered to be significant.
(70) Partial-voluming effects in the myocardium were visualized by analyzing the transmural T.sub.1 times in five rings around the myocardium from the endo- to the epi-cardial border. The rings were divided in three segments around the myocardium (septal, antero- and inferolateral). Average T.sub.1 time per segment and per ring was then compared between conventional and black-blood SAPPHIRE.
(71)
(72) Here, the imaging flip-angle may be reduced by 2 in one healthy subject due to SAR limitations. Representative T.sub.1 maps acquired with conventional and black-blood SAPPHIRE are shown as myocardial-overlays together with the corresponding T.sub.1 weighted baseline images in
(73)
(74)
(75) Here, T.sub.1-time profiles were obtained along the lines indicated in the T.sub.1 maps. As highlighted with the arrows in
(76) Here, no significant difference is found between the average T.sub.1 times of the conventional and the black-blood approach (158358 ms vs. 156256 ms, p=0.20), with slightly lower T.sub.1 time in the black-blood sequence, especially in the septal regions. However, precision, as assessed by intra-segmental T.sub.1 variation, is significantly increased using the black-blood approach (63.16.4 ms vs. 133.924.6 ms; p<0.0001). The myocardial thickness in SAPPHIRE black-blood T1 times was significantly increased by an average of 5022% compared to conventional
(77) TABLE-US-00001 TABLE 1 Average myocardial ROI thickness of conventional and black-blood T1 mapping. Average myocardial ROI thickness (mm) SHAX Slice Conventional Black-Blood Difference* Apical 4.1 0.7 6.2 1.5 52% 24% Mid 4.7 1.1 7.3 1.5 61% 33% Basal 5.1 0.8 6.8 1.0 36% 22% Average 4.6 0.7 6.8 0.8 50% 22% *p < 0.05 for all differences
(78)
(79) The average T.sub.1 times in the five septal AHA segments, which are in the vicinity of both blood-pools, were compared between conventional and black-blood SAPPHIRE at the various altered ROIs. Correlation between the septal T.sub.1 time and the ROI thickness were identified using Pearson's correlation-coefficient. Furthermore, one-way analysis of variance (ANOVA) was employed to test the T.sub.1 times at various ROI thicknesses for differences in the mean, to exclude nonlinear trends. P-values <0.05 were considered to be significant.
(80) From
(81)
(82)
(83)
(84) Beyond the loss in SNR in the baseline images, additional loss in the precision of the T1 maps can be attributed to two sources: 1) decreased resilience to imaging artifacts (such as fold-over) at lower SNR and 2) additional variation among the baseline images (caused by e.g. differences in the residual myocardial motion). In sum, T2 decay during the MSDE preparation was found to be a minor source of variability, compared to additional SNR loss, and additional variability among the base-line images.
(85) The disclosure provides a MSDE prepared SAPPHIRE sequence for blood-signal suppressed T.sub.1 mapping. Numerical simulations showed that black-blood T.sub.1 mapping benefits from decreased sensitivity to partial-voluming effects and increased apparent myocardial wall thickness. Phantom T.sub.1 times of black-blood SAPPHIRE were in good agreement with the conventional sequence. In-vivo T.sub.1 maps in healthy volunteers showed thorough blood suppression with the chosen MSDE module and robust T.sub.1 quantification in myocardial ROIs with increased thickness for the trade-off against decreased precision. Black-blood T.sub.1 mapping successfully eliminated the T.sub.1 time dependence on the ROI thickness, indicating the mitigation of partial-voluming effects and high resilience to ROI alterations.
(86) To account for these differences and to ensure optimal blood suppression that meets the requirements of quantitative imaging, a separate optimization of the MSDE preparation and the motion sensitizing gradient strength was performed. A hybrid adiabatic/composite preparation module was chosen as a trade-off between B.sub.1.sup.+ uniformity and SAR that enables thorough blood-suppression in the healthy volunteer cohort, suitable for quantitative imaging. The assessed optimal echo time (TE.sub.MSDE) leads to a first order gradient moment of m.sub.1=168 mT.Math.ms.sup.2/m.
(87) Further, to enable optimal blood-suppression with minimal signal-void in the myocardium, careful positioning of the preparation at a time-point with minimal contractile motion of the heart may be necessary. Imaging was performed at late end-diastole in order to accommodate the MSDE preparation well within the end-diastolic quiescence. A fixed echo-time TE.sub.MSDE=11 ms showed consistent T.sub.1 map quality in the healthy cohort. However, in patients with high heart-rates or arrhythmias, cardiac motion during the MSDE preparation might be unavoidable and potentially detrimental to the image quality in the proposed black-blood approach. Patient-specific adaption of the MSDE preparation may need to be performed in these cases to achieve optimal image quality. TE.sub.MSDE scouting may be needed to enable efficient selection of the patient specific optimal echo-time.
(88) In this disclosure, rapid imaging during a breath-hold eliminated these error sources and enabled reproducible T1 mapping in the left ventricle. However, depiction of the right ventricle is hindered by the lack of fat-signal suppression. A combination of fat- and blood-suppressed T.sub.1 mapping bears great promise for improved image quality and full elimination of partial-voluming caused by epicardial fat.
(89) Reproducibility in myocardial T.sub.1 mapping is paramount and affected by a number of factors, including the noise-resilience, the myocardial segment volume and the inter-observer reproducibility. On the one hand, reduced precision was shown for the proposed black-blood T.sub.1 mapping technique compared with conventional SAPPHIRE. On the other hand, an increase in the readily evaluable myocardial area has been facilitated using blood-suppression, allowing for increased segmental sizes and potentially reducing the variability of segmental T.sub.1 times.
(90) Furthermore, the black-blood technique has shown high robustness towards variation of the ROI size. Yet, careful placement of the ROIs may be crucial for conventional T.sub.1 mapping techniques, to exclude any areas of partial-voluming. As different ROI delineation may be a detrimental factor to inter-observer reproducibility, the increased robustness against ROI sizes, potentially decreases inter-observer variability.
(91) The disclosure provides a novel imaging sequence for quantitative tissue characterization of the myocardium, while eliminating detrimental effects caused by the surrounding blood-pools. T.sub.1 mapping is an emerging technique for quantitative myocardial tissue characterization that shows exceptional diagnostic and prognostic value in a plethora of ischemic and non-ischemic cardiomyopathies.
(92) T1 mapping is commonly performed based on multiple 2D single-shot images, which are acquired during the limited end-diastolic quiescence period. This in turn hinders the in-plane resolution. In conventional T1 mapping methods, this leads to the creation of a border zone at the myocardium-blood interface, that contains signal contribution from both tissue types. This effect is called partial-voluming, and leads to significant corruption of the T1 time, due to substantial differences in the T.sub.1 time between blood and myocardium.
(93) A sequence is disclosed that employs a pulse train of velocity and shear sensitizing pulses, to suppress blood signal, in a myocardial T.sub.1 mapping sequence. This allows for accurate assessment of myocardial T.sub.1 time that is resilient to contaminating effects from the blood-pools.
(94) The present disclosure has been described in terms of one or more embodiments, and it should be appreciated that many equivalents, alternatives, variations, and modifications, aside from those expressly stated, are possible and within the scope of the disclosure.